scorecardresearch
Saturday, August 16, 2025
TopicBreast cancer

Topic: breast cancer

5-yr breast cancer survival rate a dismal 66.4% in India with regional disparity, finds ICMR-led study

The study, published in American Cancer Society Journal, shows survival rate 5 yrs after diagnosis ranges from 41.9% in Pasighat to 74.9% in Mizoram. In countries like US, it's over 90%.

On dead patient’s plea, HC asks Centre for ‘best option’ to make affordable breast cancer meds available

Directive comes on 2022 plea filed by patient seeking Kerala HC's intervention to urge govt to help slash price of a critical cancer drug. She died during the course of the case.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

Cancer cases in under-50s rises by nearly 80% worldwide in last 30 years, finds BMJ study

The research found that the fastest rise was in windpipe and prostate cancers while the heaviest death toll was seen for cancers of breast, windpipe, lung, bowel, and stomach.

Asian women at higher risk of breast & cervical cancers; India lacks elimination targets: Study

Asia was also found to have the world's highest death rate from cervical cancer, with more than 58 per cent related to it.

Glenmark slashes price of HER2-positive breast cancer drug Trumab by 70%, making it cheapest in India

Breast cancer is one of the most commonly diagnosed cancers in India. Most existing Trastuzumab brands in Indian market are priced between Rs 40,000 and Rs 54,000 per 440 mg vial.

Why women with stage 4 breast cancer deserve more than unrelatable pink ribbons

Many women with metastatic breast cancer feel that little is done to showcase the less optimistic and more frightening aspects of the disease.

Experimental drug shows success in advanced breast cancer patients, better than standard chemo

Trastuzumab deruxtecan helped check cancer growth in even those with low levels of protein that cancer drugs target. Tumours didn't grow for at least 10 months, compared to average 5 in chemotherapy.

Rise of breast cancer in Indian women is alarming but expected. It’s your ‘Western’ diet

If news of breast cancer cases rising among women is shocking, it's time to leave your 'inflammatory diet'. Here's a healthier model.

1 in 7 women aged 50-74 who undergo mammogram ‘overdiagnosed’ for breast cancer, finds US study

US study looked at nearly 36,000 women who underwent screening & found that in many cases pre-cancers may not have grown into full malignancy before the women died of other causes.

On Camera

SC’s stray dog order lit a match in Delhi. Are they a menace or companions?

The last time this matter flared up was when Delhi Chief Minister Rekha Gupta, in a very similar directive in April, called for the relocation of stray dogs in the capital.

Modi’s ‘Diwali bonanza’ for the common man—next-gen GST reforms, lower tax on daily-use items soon

Finance ministry says the proposed revamp will focus on structural reforms, rate rationalisation & ease of living, & will be deliberated upon in the coming weeks.

What is Project Sudarshan Chakra, announced by Modi from ramparts of Red Fort

The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?